top of page

BMO's Evan Seigerman takes a deep dive into the obesity space ahead of an investor summit

Evan Seigerman breaks down which companies and technologies are at the forefront of the the GLP space, and which ones aren't focusing on it. Plus, recent FDA news relating to Lilly and Merck.


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page